← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2014-12-18

Drug application

FDA Application #

ANDA205217

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE

Generic name

LAMIVUDINE

Active ingredients

LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

LUPIN

Manufacturer

Lupin Pharmaceuticals, Inc.

First approval

2014-12-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown